Atomoxetine Hydrochloride Capsule
Product Images NDC 51407-101

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Atomoxetine Hydrochloride (NDC 51407-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407 100 30lb

FDA Label Image

51407 101 30lb

Atomoxetine is a medication available in the form of 18mg capsules. Each capsule contains atomoxetine hydrochloride, equivalent to 18mg of atomoxetine. The medicine should be kept in a tight container away from children and stored in a permissible temperature. The enclosed medication guide should be dispensed to each patient. The manufacturer is Apotex Inc., based in Toronto, Ontario, Canada, and the packaging is done by GSMS, Incorporated in Camarillo, CA, USA. Dosage information is available on the package insert.*

FDA Label Image

51407 102 30lb

This is a description of a medication called atomoxetine, which comes in the form of capsules containing 25mg of atomoxetine hydrochloride. The capsules are manufactured by Apotex Inc. and packaged by GSMS, Incorporated. Dosage instructions should be taken from the package insert. The medication should be kept in a tight container at a temperature between 20-26°C (68-77°F) and out of reach of children. Pharmacists should dispense medication guides with each patient prescription.*

FDA Label Image

51407 103 30lb

This is a description of Atomoxetine Capsules manufactured by GSMS Incorporated. The package contains 30 capsules of atomoxetine hydrochloride, USP equivalent to 40 mg of atomoxetine. The NDC code for these capsules is 51407-103-30. The package insert should be consulted for dosage information. The medication should be stored in a controlled room temperature between 20° to 25°C (68° to 77°F) and should be kept in a tight container. The medication guide enclosed should be dispensed to each patient by a pharmacist. The manufacturer is Apotex Inc. from Toronto, Ontario Canada, and the product is packaged by GSMS, Incorporated from Camarillo, CA 93012 USA.*

FDA Label Image

51407 104 30lb

This is a medication with the name USP available in a package containing 30 capsules, each capsule containing atomoxetine hydrochloride, USP equivalent to 60mg of atomoxetine. There are instructions on the package insert regarding dosage information. The medication should be stored at a temperature between 20 to 25°C (68" to 77°F), excursions permitted from 15° to 30°C (59° to 86°F).It should be kept out of reach of children and dispensed in a tight container by the pharmacist. It was manufactured by Apotex Inc. in Canada and packaged by GSMS, Incorporated in the USA.*

FDA Label Image

51407 105 30lb

This is a description of a medication called Atomoxetine in the form of 80 mg capsules. The medication contains Atomoxetine hydrochloride as a main ingredient. The package contains 30 capsules and dosage instructions are included in the package insert. The medication should be stored at a temperature between 20 and 25°C. The manufacturer of the medication is Apotexine from Toronto, Ontario, Canada. Additionally, the description contains information about controlling the temperature and dispensing precautions.*

FDA Label Image

51407 106 30lb

This is a bottle of Atomoxetine Capsules USP, with 100mg strength and contains 30 capsules. It is advised to read the package insert for dose information. The medicine should be kept in a tight container and out of reach of children. The pharmacist is instructed to dispense the enclosed medication guide to each patient. The product is manufactured by Apotex Inc. and packaged by GSMS, Incorporated in Camarillo, California. It should be stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F) with permitted excursions from 15°C to 30°C (59°F to 86°F).*

FDA Label Image

Atomfig1 (Atomfig1)

This appears to be a graph or chart that shows the mean height percentile over time for a group of individuals who received treatment for a period of up to 30 months. There are two groups of individuals, one with an N of 203 and another with an N of 155. The graph shows the height percentile at 6, 12, 18, 24, and 30 months of treatment.*

FDA Label Image

Atomstructure (Atomstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.